We sought to investigate the role of CCR3 in human prostate cancer and, to begin with, we studied its expression in a first tissue microarray (TMA) containing 10 normal prostate samples and 91 human prostate cancer annotated with cancer differentiation (Gleason score). This evidence concerns the gene CCR3 and prostate carcinoma.